| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KALA BIO, Inc. | Director | Common Stock | 10,374 | $41,910 | $4.04 | 15 Jun 2025 | Direct |
| ALIMERA SCIENCES INC | Chairman Emeritus | Stock Option (Right to Buy) | 6,000 | 01 Aug 2023 | Direct | ||
| KALA BIO, Inc. | Director | Stock Option (right to buy) | 5,450 | 15 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | 15 Jun 2025 | 2 | $0 | 4 | Director | 17 Jun 2025, 20:00 |
| KALA | KALA BIO, Inc. | 11 Jun 2024 | 2 | $0 | 4 | Director | 12 Jun 2024, 20:00 |
| ALIM | ALIMERA SCIENCES INC | 01 Aug 2023 | 1 | $0 | 4 | Chairman Emeritus | 03 Aug 2023, 16:23 |
| KALA | Kala Pharmaceuticals, Inc. | 22 Jun 2023 | 4 | $0 | 4 | Director | 23 Jun 2023, 20:00 |
| KALA | Kala Pharmaceuticals, Inc. | 31 May 2023 | 3 | $0 | 4 | Director | 02 Jun 2023, 20:00 |
| ALIM | ALIMERA SCIENCES INC | 04 Jan 2023 | 1 | $0 | 4 | Director | 06 Jan 2023, 16:16 |
| KALA | Kala Pharmaceuticals, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:46 |
| ALIM | ALIMERA SCIENCES INC | 02 Nov 2021 | 1 | $0 | 4 | Director | 04 Nov 2021, 20:18 |
| KALA | Kala Pharmaceuticals, Inc. | 15 Oct 2021 | 1 | $0 | 4 | Director | 19 Oct 2021, 16:08 |
| KALA | Kala Pharmaceuticals, Inc. | 15 Oct 2021 | 0 | $0 | 3 | Director | 19 Oct 2021, 16:06 |